Microscopic examination of these tissues revealed an easily observable increase in the intensity of both ASC and NLRP3 immunoreactivity in PD cases compared with controls and again indicated an intermediate phenotype in nigral cell loss patients (Fig. 1a, middle and bottom rows). The gene discussed is NLRP3; the disease is Parkinson disease.